VANCOUVER, British Columbia, 2016 /PRNewswire/ -- Clarius Mobile Health, a digital healthcare company using technology to reimagine mobile medicine, today announced the U.S. Food and Drug Administration (FDA) has cleared the C3 and L7 Clarius Wireless Ultrasound Scanners. Compatible with the latest iOS and Android smartphones and tablets, Clarius Scanners are available now for medical professionals ...
from EMS via xlomafota13 on Inoreader http://ift.tt/2hvQBOO
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Objective Among different PET tracers, 18 F-fludeoxyglucose (FDG) and 11 C-choline are known to have a high tumor uptake correl...
-
Alternative treatments for opioid use disorder and music with Dr. Ed Boyer Join Dan (@drusyniak) &Howard (@heshiegreshie) as they speak...
-
Abstract Liver transplantation is the most effective treatment for treating liver cirrhosis. However, a limited number of donors, graft re...
-
Resuscitation from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1N8kkFH
-
Abstract Lamin A/C is the major architectural protein of cell nucleus in charge of the nuclear mechanosensing. By integrating extracellula...
-
and its assessment after femoral neck fractures p. 1 Harshal Sakale, Alok C Agrawal, Bikram Keshri Kar, Bikas Sahoo, Sandeep K Yadav DOI:... -
Lymphome cérébral primitif après immunothérapie d'un mélanome métastatique Publication date: Available online 20 May 2019 Source: Annal...
-
Abstract Purpose To present a novel technique for anterior instrumentation and reconstruction with PVCR for treatment of severe neglecte...
-
Abstract Autosomal recessive primary microcephaly (MCPH) is a group of rare neurodevelopmental diseases with severe microcephaly at birth....
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου